Monitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2.
about
Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple IntegrinsSimultaneous SPECT imaging of multi-targets to assist in identifying hepatic lesionsRadiolabeled cyclic RGD peptides as radiotracers for tumor imagingImpact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptides(99m)Tc-3P-RGD2 micro-single-photon emission computed tomography/computed tomography provides a rational basis for integrin αvβ3-targeted therapy.FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues.Exploration of peptide T7 and its derivative as integrin αvβ3-targeted imaging agents.Integrin α(v)β₃-targeted radiotracer (99m)Tc-3P-RGD₂ useful for noninvasive monitoring of breast tumor response to antiangiogenic linifanib therapy but not anti-integrin α(v)β₃ RGD₂ therapy.Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects.Molecular imaging agents for SPECT (and SPECT/CT).Comparison of biological properties of 99mTc-labeled cyclic RGD Peptide trimer and dimer useful as SPECT radiotracers for tumor imaging.(99m)Tc-3PRGD 2 SPECT/CT predicts the outcome of advanced nonsquamous non-small cell lung cancer receiving chemoradiotherapy plus bevacizumab.⁹⁹mTc-3PRGD₂ SPECT to monitor early response to neoadjuvant chemotherapy in stage II and III breast cancer.
P2860
Q26801806-9DE4D9EB-AA66-4A0D-95AE-9B9616770895Q27334528-E58F64CB-7431-48EC-83B4-F5E61261BEA9Q28072021-107B5F25-2FB5-475F-BCBA-6D0FF0FFCE93Q34196969-D63F5931-CD1F-4B9F-B0D2-6E9C86B1E2C6Q34471067-B3BEB5B0-AEC7-4F2D-A545-E689F6EEAB5CQ34556242-7F882F7F-D158-423C-A6AF-944DEDA2E17BQ35760732-DDCB3CD7-E7B0-44CC-8179-5BD2E4D38932Q37344824-A67D9794-64FF-48ED-AD48-601089C74C70Q37705643-E5EFBB9F-D060-49A6-BCDB-AC8DDD3EF1A7Q38169570-CE167B22-CB1F-49EC-ABA9-A90D45B0B4EDQ38738606-3B8EAF0E-91A8-4A31-86B4-FF36BE459392Q52948537-E052183B-38EE-4010-B8CA-A9BF646EF7DEQ53515259-D2412E2B-3251-465E-939E-2987D4C379DC
P2860
Monitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Monitoring tumor response to l ...... ted radiotracer 99mTc-3P-RGD2.
@en
Monitoring tumor response to l ...... ted radiotracer 99mTc-3P-RGD2.
@nl
type
label
Monitoring tumor response to l ...... ted radiotracer 99mTc-3P-RGD2.
@en
Monitoring tumor response to l ...... ted radiotracer 99mTc-3P-RGD2.
@nl
prefLabel
Monitoring tumor response to l ...... ted radiotracer 99mTc-3P-RGD2.
@en
Monitoring tumor response to l ...... ted radiotracer 99mTc-3P-RGD2.
@nl
P2093
P2860
P356
P1476
Monitoring tumor response to l ...... ted radiotracer 99mTc-3P-RGD2.
@en
P2093
Daniel H Albert
Gerard B Fox
Guoqiang Shao
Martin J Voorbach
Sarah R Mudd
Shuang Liu
Shundong Ji
Yanping Luo
Yumin Zhang
P2860
P304
P356
10.1124/JPET.112.202622
P407
P577
2013-06-07T00:00:00Z